Invest now
Fortis Healthcare share price
Balanced risk
- ₹966.20(1.51%)July 21, 2026 13:34:52 PM IST
- NSE
- BSE
- Vol : 444.63 K (NSE + BSE)Last 20 day avg : 1.64 M
Fortis Healthcare is trading 1.51% upper at Rs 966.20 as compared to its last closing price. Fortis Healthcare has been trading in the price range of 969.60 & 950.20. Fortis Healthcare has given 7.60% in this year & -1.28% in the last 5 days. Fortis Healthcare has TTM P/E ratio 57.61 as compared to the sector P/E of 27.95.There are 17 analysts who have initiated coverage on Fortis Healthcare. There are 5 analysts who have given it a strong buy rating & 8 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.The company posted a net profit of 265.84 Crores in its last quarter.Listed peers of Fortis Healthcare include Apollo Hospitals Enterprise (-0.11%), Max Healthcare Institute (-0.84%), Aster DM Healthcare (0.80%).The Mutual Fund holding in Fortis Healthcare was at 25.72% in 31 Mar 2026. The MF holding has increased from the last quarter. The FII holding in Fortis Healthcare was at 25.98% in 31 Mar 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 21 Jul 2026, 01:34 PM IST
- BetaHigh volatility1.23Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.35The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.10Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation3.29The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Fortis Healthcare News
Fortis Healthcare Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | 8,900.00 | -0.11 | 1,27,826.17 | 65.38 | 13.48 | - | - |
| Max Healthcare Institute | 1,092.60 | -0.84 | 1,06,339.86 | 72.01 | 9.94 | - | - |
| Aster DM Healthcare | 821.10 | 0.80 | 42,295.73 | 101.57 | 9.17 | - | - |
| Narayana Hrudayalaya | 1,999.40 | -1.32 | 40,700.89 | 48.19 | 9.11 | - | - |
| Global Health | 1,341.35 | 0.71 | 35,965.72 | 64.39 | 9.03 | - | - |
Mutual Fund Ownership
View allFortis Healthcare Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-22 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-06 | Quarterly Results & Others |
| 2025-05-20 | Audited Results & Final Dividend |
About the company Fortis Healthcare
- IndustryHealthcare Facilities
- ISININE061F01013
- BSE Code532843
- NSE CodeFORTIS
Fortis Healthcare Limited is an India-based integrated healthcare service provider. The Company is primarily engaged in the business of healthcare services. Its segment includes the Healthcare business and the Diagnostics business. The healthcare business includes inpatient and outpatient services, sale of medical and nonmedical items and management fees from hospitals. The diagnostic business includes pathology and radiology services. Its specialties include Cardiac sciences, Oncology, Neurosciences, Gastroenterology, Orthopedics, and others. The healthcare verticals of the Company primarily consist of day care specialty, diagnostics and tertiary and quaternary care. The Company has approximately 27 healthcare facilities in India, 4750 operational beds. It operates in India, United Arab Emirates, Nepal, and Sri Lanka.
Fortis Healthcare Share Price FAQs
Fortis Healthcare is trading at 966.20 as on Tue Jul 21 2026 08:04:52. This is 1.51% upper as compared to its previous closing price of 951.85.
The market capitalization of Fortis Healthcare is 72872.68 Cr as on Tue Jul 21 2026 08:04:52.
The average broker rating on Fortis Healthcare is Buy. The breakup of analyst rating is given below -
- 5 analysts have given a strong buy rating
- 8 analysts have given a buy rating
- 3 analysts have given a hold rating
- 1 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Fortis Healthcare is 1105.00 whereas the 52 wk low is 767.30
Fortis Healthcare can be analyzed on the following key metrics -
- TTM P/E: 57.61
- Sector P/E: 27.95
- Dividend Yield: 0.11%
- D/E ratio: 0.35
Fortis Healthcare reported a net profit of 1041.77 Cr in 2026.
The Mutual Fund Shareholding was 25.72% at the end of 31 Mar 2026.
Quick Links
EQUITY QUICK LINKS
Fortis Healthcare QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.